| __timestamp | Arrowhead Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 72471000 |
| Thursday, January 1, 2015 | 34718089 | 89204000 |
| Friday, January 1, 2016 | 40998209 | 106010000 |
| Sunday, January 1, 2017 | 32022880 | 137905000 |
| Monday, January 1, 2018 | 19110051 | 159888000 |
| Tuesday, January 1, 2019 | 26556257 | 158425000 |
| Wednesday, January 1, 2020 | 52275890 | 200677000 |
| Friday, January 1, 2021 | 80981000 | 304759000 |
| Saturday, January 1, 2022 | 124431000 | 377221000 |
| Sunday, January 1, 2023 | 90932000 | 336361000 |
| Monday, January 1, 2024 | 98761000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, operational efficiency is key. Arrowhead Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Arrowhead's SG&A expenses surged by approximately 300%, peaking in 2022. This reflects their aggressive expansion and investment in operational capabilities. In contrast, Supernus Pharmaceuticals experienced a more than 400% increase in SG&A expenses, with a notable peak in 2022, indicating a robust growth strategy. However, data for 2024 is missing for Supernus, leaving room for speculation on their current trajectory. These trends highlight the dynamic nature of the pharmaceutical industry, where strategic spending can significantly impact market positioning. As these companies continue to evolve, their SG&A expenses will remain a critical indicator of their operational strategies and market ambitions.
Amgen Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? GSK plc or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Catalent, Inc. vs Supernus Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Arrowhead Pharmaceuticals, Inc.
Grifols, S.A. or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Merus N.V. and Supernus Pharmaceuticals, Inc.
HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Arrowhead Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.